New drug forms tested in healthy volunteers
NCT ID NCT05727189
Summary
This is an early safety study testing three different forms of an extended-release drug called TR-01-XR in healthy adults. Researchers will enroll 150 participants to check for side effects and measure how the body absorbs and processes each drug form. The goal is to gather basic safety data and understand how the drug behaves in people before testing it in patients with specific conditions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CMAX Clinical Research
Adelaide, South Australia, 5000, Australia
-
Scientia Clinical Research
Randwick, New South Wales, 2031, Australia
Conditions
Explore the condition pages connected to this study.